These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 10557047

  • 21. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
    Florena AM, Tripodo C, Iannitto E, Porcasi R, Ingrao S, Franco V.
    Haematologica; 2004 Aug; 89(8):911-9. PubMed ID: 15339673
    [Abstract] [Full Text] [Related]

  • 22. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlué J, Büsche G, Kreipe H.
    Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
    [Abstract] [Full Text] [Related]

  • 23. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J, Kvasnicka HM.
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Diehl V.
    Histopathology; 2003 Nov; 43(5):470-9. PubMed ID: 14636273
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.
    Kvasnicka HM, Thiele J, Regn C, Zankovich R, Diehl V, Fischer R.
    Ann Hematol; 1999 Feb; 78(2):65-72. PubMed ID: 10089020
    [Abstract] [Full Text] [Related]

  • 29. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J, Simon KG, Fischer R, Zankovich R.
    Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
    [Abstract] [Full Text] [Related]

  • 30. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A, Weiss M, Wiese B, Choritz H, Buhr T, Büsche G, Georgii A.
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [Abstract] [Full Text] [Related]

  • 31. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].
    Buhr T, Länger F, Kreft A, Büsche G, Choritz H, Kreipe H.
    Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296
    [Abstract] [Full Text] [Related]

  • 32. Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis.
    Thiele J, Lorenzen J, Manich B, Kvasnicka HM, Zirbes TK, Fischer R.
    Acta Haematol; 1997 Nov; 97(3):137-43. PubMed ID: 9066708
    [Abstract] [Full Text] [Related]

  • 33. Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.
    Gianelli U, Vener C, Raviele PR, Moro A, Savi F, Annaloro C, Somalvico F, Radaelli F, Franco V, Deliliers GL.
    Leuk Lymphoma; 2006 Sep; 47(9):1774-81. PubMed ID: 17064987
    [Abstract] [Full Text] [Related]

  • 34. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Flucke U, Spoer C, Paperno S, Leder LD, Schaefer UW.
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [Abstract] [Full Text] [Related]

  • 35. Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.
    Barosi G.
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):129-40. PubMed ID: 25189724
    [Abstract] [Full Text] [Related]

  • 36. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
    Buhr T, Büsche G, Choritz H, Länger F, Kreipe H.
    Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
    [Abstract] [Full Text] [Related]

  • 37. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.
    Kamiunten A, Shide K, Kameda T, Ito M, Sekine M, Kubuki Y, Hidaka T, Akizuki K, Tahira Y, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Shimoda H, Yamashita K, Matsuoka H, Shimoda K.
    Int J Hematol; 2018 Oct; 108(4):411-415. PubMed ID: 29987745
    [Abstract] [Full Text] [Related]

  • 38. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H.
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [Abstract] [Full Text] [Related]

  • 39. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.
    Bock O, Loch G, Schade U, Büsche G, Wasielewski R, Wiese B, Kreipe H.
    Br J Haematol; 2005 Jul; 130(1):76-82. PubMed ID: 15982347
    [Abstract] [Full Text] [Related]

  • 40. [Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone].
    Tanosaki R, Uchida H, Masuda Y, Michikawa N, Ogawa T, Kubo A, Ikeda Y.
    Rinsho Ketsueki; 1992 Feb; 33(2):256-8. PubMed ID: 1635179
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.